MHRP's African Cohort Study, or AFRICOS, represents the intersection of research and global health programming to bring about an end to HIV. At the AIDS 2024 conference, researchers shared a wealth of data and findings from the AFRICOS study on topics ranging from the neurocognitive effects of HIV in young people, to food insecurity among PEPFAR clients, to hypertension and cardiovascular health in people living with HIV, and more.
Charity’s life took an unexpected turn when she was taken from her village to Abuja, Nigeria’s bustling capital, by a relative who promised her a better life. However, upon arrival, those promises crumbled into a harsh reality. Charity was forced to work as a waiter and sex worker in the restaurant and guest house owned by her relative. Her life was fraught with exploitation and abuse.
MHRP and partners across four continents recently launched a new collaborative HIV cure research initiative called DELIVER, or Developing Leadership and Innovation in Viral Eradication Research.
MHRP is partnering with the Makerere University Walter Reed Project (MUWRP) in Uganda to conduct a novel HIV vaccine study called “RapidVax,” which recently started in March 2024. This study (RV591) combines experimental HIV vaccines with a novel dose escalation strategy with the goal of improving the body’s immune response.